Biosimilars: US FDA Regulatory Science Research ROI Still To Be Determined

 
• By Derrick Gingery
  
Many biosimilar regulatory science research program awardees focused on immunogenicity. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from United States